Crossmark

Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications

Crossref DOI link: https://doi.org/10.1007/s00277-020-04196-y

Published Online: 2020-07-31

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chuang, Tzu-Yao

Li, Ju-Pi

Weng, Te-Fu

Wu, Kang-Hsi

Chao, Yu-Hua https://orcid.org/0000-0003-1727-5847
License Information

Text and Data Mining valid from 2020-07-31

Version of Record valid from 2020-07-31
More Information

Article History

Received: 11 April 2020

Accepted: 20 July 2020

First Online: 31 July 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: This study was approved by the institutional review board of the China Medical University Hospital, and written informed consents were obtained from the patients. All procedures followed were in accordance with the 1964 Helsinki declaration and its later amendments.

Document is current

Any future updates will be listed below